DRDavid Rouquié

David Rouquié

*This is an algorithmically generated author record based on publicly available information.

David Rouquié has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Machine Learning for Toxicity Prediction Using Chemical Structures: Pillars for Success in the Real World

    by Srijit Seal, Manas Mahale, Miguel García-Ortegón, Chaitanya K. Joshi, Layla Hosseini-Gerami, Alex Beatson, Matthew Greenig, Mrinal Shekhar, Arijit Patra, Caroline Weis, et al.

    Machine learning (ML) is increasingly valuable for predicting molecular properties and toxicity in drug discovery. However, toxicity-related end points have always been challenging to evaluate experimentally with respect to in vivo translation due to the required resources for human and animal studies; this has impacted data availability in the field. ML can augment or even potentially replace traditional experimental processes depending on the project phase and specific goals of the prediction. For instance, models can be used to select promising compounds for on-target effects or to deselect those with undesirable characteristics (e.g., off-target or ineffective due to unfavorable pharmacokinetics). However, reliance on ML is not without risks, due to biases stemming from nonrepresentative training data, incompatible choice of algorithm to represent the underlying data, or poor model building and validation approaches. This might lead to inaccurate predictions, misinterpretation of the confidence in ML predictions, and ultimately suboptimal decision-making. Hence, understanding the predictive validity of ML models is of utmost importance to enable faster drug development timelines while improving the quality of decisions. This perspective emphasizes the need to enhance the understanding and application of machine learning models in drug discovery, focusing on well-defined data sets for toxicity prediction based on small molecule structures. We focus on five crucial pillars for success with ML-driven molecular property and toxicity prediction: (1) data set selection, (2) structural representations, (3) model algorithm, (4) model validation, and (5) translation of predictions to decision-making. Understanding these key pillars will foster collaboration and coordination between ML researchers and toxicologists, which will help to advance drug discovery and development.


  • Cell Painting and Chemical Structure Read-Across Can Complement Each Other for Rat Acute Oral Toxicity Prediction in Chemical Early Derisking

    by Fabrice Camilleri, Joanna M. Wenda, Claire Pecoraro-Mercier, Jean-Paul Comet, David Rouquié

    Early derisking decisions in the development of new chemical compounds enable the identification of novel chemical candidates with improved safety profiles. In vivo studies are traditionally conducted in the early assessment of acute oral toxicity of crop protection products to avoid compounds, which are considered "very acutely toxic", with an in vivo lethal dose of 50% (LD50) ≤ 60 mg/kg body weight. Those studies are lengthy and costly and raise ethical concerns, catalyzing the use of nonanimal alternatives. The objective of our analysis was to assess the predictive efficacy of read-across approaches for acute oral toxicity in rats, comparing the use of chemical structure information, in vitro biological data derived from the Cell Painting profiling assay on U2OS cells, or the combination of both. Our findings indicate that the classification of compounds as very acute oral toxic (LD50 ≤ 60 mg/kg) or not is possible using a read-across approach, with chemical structure information, morphological profiles, or a combination of both. When classifying compounds structurally similar to those in the training set, the chemical structure was more predictive (balanced accuracy of 0.82). Conversely, when the compounds to be classified were structurally different from those in the training set, the morphological profiles were more predictive (balanced accuracy of 0.72). Combining the two models allowed for the classification of compounds structurally similar to those in the training set to slightly improve the predictions (balanced accuracy of 0.85).


  • Open Access

    Assessment of Drug-Induced Liver Injury through Cell Morphology and Gene Expression Analysis

    by Vanille Lejal, Natacha Cerisier, David Rouquié, Olivier Taboureau

    Drug-induced liver injury (DILI) is a significant concern in drug development, often leading to drug withdrawal. Although many studies aim to identify biomarkers and gene/pathway signatures related to liver toxicity and aim to predict DILI compounds, this remains a challenge in drug discovery. With a strong development of high-content screening/imaging (HCS/HCI) for phenotypic screening, we explored the morphological cell perturbations induced by DILI compounds. In the first step, cell morphological signatures were associated with two datasets of DILI chemicals (DILIRank and eTox). The mechanisms of action were then analyzed for chemicals having transcriptomics data and sharing similar morphological perturbations. Signaling pathways associated with liver toxicity (cell cycle, cell growth, apoptosis, ...) were then captured, and a hypothetical relation between cell morphological perturbations and gene deregulation was illustrated within our analysis. Finally, using the cell morphological signatures, machine learning approaches were developed to predict chemicals with a potential risk of DILI. Some models showed relevant performance with validation set balanced accuracies between 0.645 and 0.739. Overall, our findings demonstrate the utility of combining HCI with transcriptomics data to identify the morphological and gene expression signatures related to DILI chemicals. Moreover, our protocol could be extended to other toxicity end points, offering a promising avenue for comprehensive toxicity assessment in drug discovery.


  • Stacked Generalization with Applicability Domain Outperforms Simple QSAR on in Vitro Toxicological Data

    by Ingrid Grenet, Kevin Merlo, Jean-Paul Comet, Romain Tertiaux, David Rouquié, Frédéric Dayan

    The development of in silico tools able to predict bioactivity and toxicity of chemical substances is a powerful solution envisioned to asess toxicity as early as possible. To enable the development of such tools, the ToxCast program has generated and made publicly available in vitro bioactivity data for thousands of compounds. The goal of the present study is to characterize and explore the data from ToxCast in terms of Machine Learning capacity. For this, a large scale analysis on the entire database has been performed to build models to predict bioactivities measured in in vitro assays. Simple classical QSAR algorithms (ANN, SVM, LDA, Random Forest and Bayesian) were first applied on the data, and the results of these algorithms suggested that they do not seem to be well suited for datasets with a high proportion of inactive compounds. The study then showed for the first time that the use of an ensemble method named "Stacked generalization" could improve the model performance on this type of data. Indeed, for 61% of 483 models, the Stacked method led to models with higher performance. Moreover, the combination of this ensemble method with an applicability domain filter allows one to assess the reliability of the predictions for further compound prioritization. In particular we showed that for 50% of the models, the ROC score is better if we do not consider the compounds that are not within the applicability domain.


  • Comparison of early morphological and molecular changes induced by 17-alpha-methyltestosterone and estradiol benzoate in the rat ovary

    by Céline Ferre, Sara Belluco, Helen Tinwell, Rémi Bars, Mohamed Benahmed, David Rouquie, Frédéric Schorsch